Chien‐Yu Cheng

Ministry of Health and Welfare — South Korea

Medicine · Health Sciences

25h-index2.7kcitations130works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(37), SARS-CoV-2 and COVID-19 Research(31), Hepatitis C virus research(31), COVID-19 Clinical Research Studies(27), HIV Research and Treatment(19)

Publications125 total

Dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate: Real-world assessment of effectiveness and weight Gain in naïve people living with HIV of Asian OrigiN (DRAGON)
International Journal of Infectious Diseases·2025Open Access
Dolutegravir + lamivudine effectiveness and tolerability in real-world cohorts with HIV-1 across Asia and South America: A systematic literature review
Medicine·2025· 1 citedOpen Access
Concordance of Oral and Anal Human Papillomavirus in Men Who Have Sex With Men Living With Human Immunodeficiency Virus
Journal of Oral Pathology and Medicine·2025
Disproportionate presentation of Mpox among people with HIV: A multicenter retrospective cohort study in Taiwan
Journal of Microbiology Immunology and Infection·2025· 1 citedOpen Access
Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan
The Kaohsiung Journal of Medical Sciences·2025Open Access
Risk factors for mpox infection among MSM with STIs in northern Taiwan, 2022–2024
Journal of Infection and Chemotherapy·2025· 1 citedOpen Access
Awareness and willingness towards Mpox vaccination among men who have sex with men seeking HIV-related services
Journal of the Formosan Medical Association·2025· 3 citedOpen Access
Molecular screening of wild and cultivated tomato germplasm reveals potential materials for multi-locus disease resistance breeding
Genetic Resources and Crop Evolution·2025Open Access
WED-272 Real-world efficacy and safety of universal 8-week Glecaprevir/ Pibrentasvir in CHC patients with early CKD or Pre-ESRD: insights from a nationwide HCV registry in Taiwan
Journal of Hepatology·2025
Author response for "Concordance of Oral and Anal Human Papillomavirus in Men Who Have Sex With Men Living With Human Immunodeficiency Virus"
2025
Prevalence of Naturally Occurring HIV-1 Capsid Inhibitor Resistance–Related Mutations in Antiretroviral Therapy–Naïve and –Experienced Individuals in Taiwan
Open Forum Infectious Diseases·2025· 2 citedOpen Access
Week 48 Results from Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/ Tenofovir Alafenamide Fumarate: Real-World Assessment of Weight Gain in Naïve People Living with HIV of Asian OrigiN (Dragon)
Preprints.org·2025Open Access
Oncogenic human papillomavirus and anal microbiota in men who have sex with men and are living with HIV in Northern Taiwan
PLoS ONE·2024Open Access
IoT‐Based Hand Hygiene Compliance Monitoring System and Validation of Its Effectiveness in Hospital Environments (Global Challenges 12/2024)
Global Challenges·2024· 1 citedOpen Access
Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study
Human Vaccines & Immunotherapeutics·2024Open Access
Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIV
PLoS ONE·2024· 3 citedOpen Access
Drug monitoring was conducted for rifapentine among people with HIV receiving dolutegravir containing antiretroviral therapy and latent tuberculosis treatment
Journal of Microbiology Immunology and Infection·2024Open Access
IoT‐Based Hand Hygiene Compliance Monitoring System and Validation of Its Effectiveness in Hospital Environments
Global Challenges·2024· 3 citedOpen Access
Impact of HCV eradication by directly acting antivirals on glycemic indices in chronic hepatitis C patients -a nationwide Taiwan HCV registry
Journal of the Formosan Medical Association·2024· 6 citedOpen Access
Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan
Digestive Diseases and Sciences·2024· 3 cited
page 1 of 7Next →

Frequent Co-authors

Shu‐Hsing Cheng(33), Cheng‐Pin Chen(20), Yi‐Chun Lin(14), Chien‐Ching Hung(12), Hsin‐Yun Sun(10), Chia‐Jui Yang(10), Hung-Jen Tang(10), Yu-Lin Lee(9), Chun-Eng Liu(8), Yuan‐Ti Lee(8), Ning‐Chi Wang(8), Shih‐Ping Lin(8), Yu‐Shan Huang(8), Mao‐Song Tsai(7), Tsung‐Chia Chen(6), Wei‐Sheng Chung(6), Yi-Wen Huang(6), Cheng-Yu Kuo(6), Wu-Pu Lin(6), Tse-Hung Lin(6)